OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current epidemiology of cholangiocarcinoma in Western countries
Mathew Vithayathil, Shahid A. Khan
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1690-1698
Closed Access | Times Cited: 105
Mathew Vithayathil, Shahid A. Khan
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1690-1698
Closed Access | Times Cited: 105
Showing 51-75 of 105 citing articles:
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression
Maria Adriana Cocozza, Elton Dajti, Lorenzo Braccischi, et al.
CardioVascular and Interventional Radiology (2024) Vol. 47, Iss. 10, pp. 1313-1324
Open Access | Times Cited: 1
Maria Adriana Cocozza, Elton Dajti, Lorenzo Braccischi, et al.
CardioVascular and Interventional Radiology (2024) Vol. 47, Iss. 10, pp. 1313-1324
Open Access | Times Cited: 1
Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma
Baoluhe Zhang, Bao Jin, Xiangan Wu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Baoluhe Zhang, Bao Jin, Xiangan Wu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Lymph node metastasis of intrahepatic cholangiocarcinoma: the present and prospect of detection and dissection
Ruoyu Zhang, Yunfei Tan, Mei Liu, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 12, pp. 1359-1369
Open Access | Times Cited: 1
Ruoyu Zhang, Yunfei Tan, Mei Liu, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 12, pp. 1359-1369
Open Access | Times Cited: 1
Research trends of targeted therapy for cholangiocarcinoma from 2003 to 2022: a bibliometric and visual analysis
Peng Huang, Feng Wen, Qiuji Wu, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3981-3994
Closed Access | Times Cited: 3
Peng Huang, Feng Wen, Qiuji Wu, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3981-3994
Closed Access | Times Cited: 3
Telomere length and risk of cirrhosis, hepatocellular carcinoma, and cholangiocarcinoma in 63,272 individuals from the general population
Helene Gellert‐Kristensen, Stig E. Bojesen, Anne Tybjærg Hansen, et al.
Hepatology (2023) Vol. 79, Iss. 4, pp. 857-868
Closed Access | Times Cited: 3
Helene Gellert‐Kristensen, Stig E. Bojesen, Anne Tybjærg Hansen, et al.
Hepatology (2023) Vol. 79, Iss. 4, pp. 857-868
Closed Access | Times Cited: 3
Cohort study to assess geographical variation in cholangiocarcinoma treatment in England
Sophie Jose, Amy Zalin‐Miller, Craig Knott, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 12, pp. 2077-2092
Open Access | Times Cited: 3
Sophie Jose, Amy Zalin‐Miller, Craig Knott, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 12, pp. 2077-2092
Open Access | Times Cited: 3
Biliary tract cancers have distinct epidemiological patterns and clinical characteristics according to tumour site
François Ghiringhelli, Valérie Jooste, Sylvain Manfrédi, et al.
HPB (2023) Vol. 25, Iss. 6, pp. 693-703
Open Access | Times Cited: 3
François Ghiringhelli, Valérie Jooste, Sylvain Manfrédi, et al.
HPB (2023) Vol. 25, Iss. 6, pp. 693-703
Open Access | Times Cited: 3
Revision of potential prognostic markers of cholangiocarcinoma for clinical practice
Charupong Saengboonmee, Sumalee Obchoei, Kanlayanee Sawanyawisuth, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 5, pp. 517-530
Closed Access | Times Cited: 2
Charupong Saengboonmee, Sumalee Obchoei, Kanlayanee Sawanyawisuth, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 5, pp. 517-530
Closed Access | Times Cited: 2
NOTCH signalling – a core regulator of bile duct disease?
Anabel Martinez Lyons, Luke Boulter
Disease Models & Mechanisms (2023) Vol. 16, Iss. 9
Open Access | Times Cited: 2
Anabel Martinez Lyons, Luke Boulter
Disease Models & Mechanisms (2023) Vol. 16, Iss. 9
Open Access | Times Cited: 2
Hepatic Arterial Infusion Chemotherapy with or without Lenvatinib for Unresectable Cholangiocarcinoma: A Single-Center Retrospective Study
Yajing Wang, Zhanqi Wei, Zheng Zhang, et al.
Hepatic Oncology (2023) Vol. 10, Iss. 2
Open Access | Times Cited: 2
Yajing Wang, Zhanqi Wei, Zheng Zhang, et al.
Hepatic Oncology (2023) Vol. 10, Iss. 2
Open Access | Times Cited: 2
Application of tumor microparticles in tumor prevention and treatment
Weiwei Sun, Pingwei Xu, Pengtao Pan, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Weiwei Sun, Pingwei Xu, Pengtao Pan, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Establishment and validation of a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with perineural invasion.
Maobing Wang, Zhaowei Sun, Qinlei Wang, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5082-5093
Closed Access | Times Cited: 2
Maobing Wang, Zhaowei Sun, Qinlei Wang, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5082-5093
Closed Access | Times Cited: 2
Pancreatic and Biliary Tract Cancers
Alexander Ney, Daniel Osei‐Bordom, Andrés García-Sampedro, et al.
(2024), pp. 291-320
Closed Access
Alexander Ney, Daniel Osei‐Bordom, Andrés García-Sampedro, et al.
(2024), pp. 291-320
Closed Access
Preoperative CT and MRI assessment of the longitudinal tumor extent of extrahepatic bile duct cancer after biliary drainage
S. Cho, Yeun‐Yoon Kim, June Park, et al.
Diagnostic and Interventional Radiology (2024)
Open Access
S. Cho, Yeun‐Yoon Kim, June Park, et al.
Diagnostic and Interventional Radiology (2024)
Open Access
A novel diagnosis model of cholangiocarcinoma for ERCP patients underwent Spyglass: development, validation, and clinical utility of an online platform
Minghong Shi, Xu Zhang, Jia Chen, et al.
Research Square (Research Square) (2024)
Open Access
Minghong Shi, Xu Zhang, Jia Chen, et al.
Research Square (Research Square) (2024)
Open Access
Prognostic nomogram for cholangiocarcinoma after immunotherapy
Chao Chen, Zhan Shi, Xiaoyuan Chu, et al.
Research Square (Research Square) (2024)
Open Access
Chao Chen, Zhan Shi, Xiaoyuan Chu, et al.
Research Square (Research Square) (2024)
Open Access
Clinicopathological features, prognostic factors, and prognostic survival prediction in patients with extrahepatic bile duct cancer liver metastasis
Xianyu Huang, Wenhui Chen, Jiaxin Liu, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 8, pp. 1029-1037
Open Access
Xianyu Huang, Wenhui Chen, Jiaxin Liu, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 8, pp. 1029-1037
Open Access
Efficacy and safety of maintenance therapy with anlotinib for advanced cholangiocarcinoma after first-line chemotherapy and the variations in efficacy based on different neutrophil-to-lymphocyte ratio (NLR)
Hui Li, Jue Zhang, Lili Gu
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access
Hui Li, Jue Zhang, Lili Gu
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access
Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression
Deng Xiang, Min Wang, Hua‐Jun Wu, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 5, pp. 669-683
Closed Access
Deng Xiang, Min Wang, Hua‐Jun Wu, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 5, pp. 669-683
Closed Access
Causal Relationship Among Intestinal Microbiota, Lipid Metabolites, and Cholangiocarcinoma: A Mendelian Randomization Study
Sicheng Xu, Xing He, Liqiang Liu, et al.
Research Square (Research Square) (2024)
Open Access
Sicheng Xu, Xing He, Liqiang Liu, et al.
Research Square (Research Square) (2024)
Open Access
Personalized treatment of perihilar cholangiocarcinoma based on tumor genetic and molecular characteristics
He-Nan Tang, Ming-Wei Wang, Xuesong Liu, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 9, pp. 2769-2773
Closed Access
He-Nan Tang, Ming-Wei Wang, Xuesong Liu, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 9, pp. 2769-2773
Closed Access
Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial
Jianwei Liu, Shilei Bai, Yanfu Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Jianwei Liu, Shilei Bai, Yanfu Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Evaluation of Long Axial Field-of-View (LAFOV) PET/CT for Post-Treatment Dosimetry in Yttrium-90 Radioembolization of Liver Tumors: A Comparative Study with Conventional SPECT Imaging
Konstantinos Zeimpekis, Hasan Sari, Nasir Gözlügöl, et al.
Research Square (Research Square) (2024)
Closed Access
Konstantinos Zeimpekis, Hasan Sari, Nasir Gözlügöl, et al.
Research Square (Research Square) (2024)
Closed Access
Machine Learning Model Based on Dynamic Contrast-Enhanced Ultrasound Assisting LI-RADS Diagnosis of HCC: A Multicenter Diagnostic Study
Meiqin Xiao, Yishu Deng, Wei Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38850-e38850
Open Access
Meiqin Xiao, Yishu Deng, Wei Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e38850-e38850
Open Access
Artificial intelligence for detection and characterization of focal hepatic lesions: a review
Julia Arribas Anta, Juan Moreno‐Vedia, Javier García López, et al.
Abdominal Radiology (2024)
Closed Access
Julia Arribas Anta, Juan Moreno‐Vedia, Javier García López, et al.
Abdominal Radiology (2024)
Closed Access
